Maternal dietary creatine supplementation does not alter the capacity for creatine synthesis in the newborn spiny mouse

Hayley Dickinson, Zoe Jane Ireland, Domenic A LaRosa, Bree Aimee O'Connell, Stacey Joan Ellery, Rodney Snow, David William Walker

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)


We have previously reported that maternal creatine supplementation protects the neonate from hypoxic injury. Here, we investigated whether maternal creatine supplementation altered expression of the creatine synthesis enzymes (arginine:glycine amidinotransferase [AGAT], guanidinoaceteate methyltransferase [GAMT]) and the creatine transporter (solute carrier family 6 [neurotransmitter transporter, creatine] member 8: SLC6A8) in the term offspring. Pregnant spiny mice were fed a 5 creatine monohydrate diet from midgestation (day 20) to term (39 days). Placentas and neonatal kidney, liver, heart, and brain collected at 24 hours of age underwent quantitative polymerase chain reaction and Western blot analysis. Maternal creatine had no effect on the expression of AGAT and GAMT in neonatal kidney and liver, but mRNA expression of AGAT in brain tissues was significantly decreased in both male and female neonates born to mothers who were fed the creatine diet. SLC6A8 expression was not affected by maternal dietary creatine loading in any tissues. Maternal dietary creatine supplementation from midgestation in the spiny mouse did not alter the capacity for creatine synthesis or transport.
Original languageEnglish
Pages (from-to)1096 - 1102
Number of pages7
JournalReproductive Sciences
Issue number9
Publication statusPublished - 2013

Cite this